ICER Report Highlights Efficacy and Value of Targeted Therapies for Plaque Psoriasis
August 7th 2018In its latest report, the Institute for Clinical and Economic Review (ICER) evaluated the efficacy and value of newer targeted agents that treat moderate-to-severe plaque psoriasis compared with non-targeted therapies.
Read More
California Insurance Commissioner Urges DOJ to Block Aetna, CVS Merger
August 6th 2018The California insurance commissioner, who has spoken out against other large healthcare mergers, this week asked the Department of Justice (DOJ) to block the $69 billion deal combining Aetna with CVS Health.
Read More
New Data Support Move to Single-Tablet Darunavir-Based Regimen for Treating HIV
August 3rd 2018New research demonstrates continued virologic control in patients with HIV-1 following a switch to Symtuza (darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg, and tenofovir alafenamide 10 mg [D/C/F/TAF]) regardless of prior treatment regimen
Read More